In 2011, the US Preventive Service Task Force (USPSTF) recommended that serum PSA-based measurements should not be used to screen men for the presence of prostate cancer. Now, research shows that, following this recommendation, a 28% decline in incident diagnosis of prostate cancer has occurred. Despite this decrease, however, new diagnoses of non-localized prostate cancer have remained unchanged. Only time will tell if this decision has indeed prevented the overdiagnosis of prostate cancer.
References
Barocas, D. A. et al. The effect of the United States Preventive Services Task Force grade D recommendation against screening for prostate cancer on incident prostate cancer diagnoses in the US. J. Urol. 10.1016/j.juro.2015.06.075
Rights and permissions
About this article
Cite this article
USPSTF recommendations reduce diagnosis of new cases. Nat Rev Urol 12, 417 (2015). https://doi.org/10.1038/nrurol.2015.163
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2015.163
